Price $244.78 |
Market Cap
22.08B
|
Sector Health Care |
Div. Growth
5.90%
|
|
P/E
24.9
|
P/B
5.29
|
P/S
5.14
|
Dividend %
1.30%
|
|
P/CF
-
|
P/FCF
41.0
|
Op. Cash Flow
934.9K
|
FCF
3.7
|
|
Op. Margin
26.60%
|
Net Margin
20.70%
|
ROE
22.60%
|
ROI
17.00%
|
|
ROA
13.50%
|
EPS Growth
14.80%
|
Current Ratio
3.1
|
Debt/Equity
34.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc (SXTC) | $0.59 | - | - | 1.2M | Strong Buy |
| CordovaCann Corp (LVRLF) | $0.06 | - | - | 12.6M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
